Walgreens Boots Alliance, Inc. (WBA) Analysts See $1.43 EPS

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Logo

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.43 EPS on January, 3.They anticipate $0.15 EPS change or 11.72 % from last quarter’s $1.28 EPS. WBA’s profit would be $1.36 billion giving it 14.50 P/E if the $1.43 EPS is correct. After having $1.48 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see -3.38 % EPS growth. The stock increased 0.14% or $0.12 during the last trading session, reaching $82.94. About 94 shares traded. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has declined 14.94% since December 7, 2017 and is downtrending. It has underperformed by 30.56% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 12 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 2 have Buy rating, 1 Sell and 9 Hold. Therefore 17% are positive. Walgreens Boots Alliance had 15 analyst reports since June 27, 2018 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, June 27 by Pivotal Research. The rating was maintained by Citigroup with “Neutral” on Friday, October 12. The firm earned “Neutral” rating on Monday, July 2 by Mizuho. The firm has “Outperform” rating given on Monday, October 8 by RBC Capital Markets. Evercore downgraded the stock to “In-Line” rating in Tuesday, July 10 report. As per Tuesday, September 11, the company rating was maintained by Robert W. Baird. The rating was maintained by JP Morgan with “Overweight” on Monday, October 8. The rating was downgraded by Robert W. Baird on Friday, June 29 to “Neutral”. Morgan Stanley maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) rating on Monday, December 3. Morgan Stanley has “Equal-Weight” rating and $77 target. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has “Neutral” rating given on Friday, October 12 by Robert W. Baird.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $78.72 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 16.42 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

More notable recent Walgreens Boots Alliance, Inc. (NASDAQ:WBA) news were published by: Nasdaq.com which released: “Upcoming Earnings to Watch: WBA, DAL, JPM – Nasdaq” on October 05, 2018, also Nasdaq.com with their article: “BIL, EDOW: Big ETF Inflows – Nasdaq” published on November 21, 2018, Nasdaq.com published: “Is Walgreens Boots (WBA) a Great Stock for Value Investors? – Nasdaq” on June 15, 2018. More interesting news about Walgreens Boots Alliance, Inc. (NASDAQ:WBA) were released by: Seekingalpha.com and their article: “Walgreens Boots Alliance settles case with SEC – Seeking Alpha” published on September 28, 2018 as well as Seekingalpha.com‘s news article titled: “Walgreens: The Bezos Bottom – Seeking Alpha” with publication date: October 22, 2018.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.